Experts working in artificial intelligence, from technological to public policy roles, discuss the critical turning point we are experiencing in AI and what it means for the future

Jeremy Bailenson, BS ’94, served as one of the consultants on the $2.3-billion Sphere in Las Vegas, the groundbreaking immersive entertainment venue. Extended reality isn’t just for play, he says. Impactful learning experiences are among the technology’s most impressive benefits.

Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group of U-M scientists is leveraging these avenues to explore the growing foundation of new potential therapies.

This proven and peer-led mental wellness program, created by a U-M scientist (and WW success story), seeks to help people who shun or can’t afford traditional therapy. Like the popular weight-loss program, it’s community-based, inexpensive, and — best of all — scaling up.

Technique developed at U-M provides a noninvasive alternative to surgery, chemotherapy, and radiation treatments for cancer. A human trial underway since 2021 at the Rogel Cancer Center and other locations demonstrates the technology’s ability to meet the testing’s primary effectiveness and safety targets.

As artificial intelligence apps such as ChatGPT have proliferated, so have chatbots with a religious bent. In this video and Q&A, Webb Keane, U-M professor of anthropology, shares his thoughts about so-called “godbots,” and the danger of giving moral authority to artificial intelligence.

A gene sequencing method called ribosome profiling has expanded our understanding of the human genome by identifying previously unknown protein coding regions. Also known as Ribo-seq, this method allows researchers to get a high-resolution snapshot of protein production in cells.

The fast-acting pill, paired with psychosocial treatment, offers a comprehensive treatment plan, but price concerns remain

Research led by the University of Michigan generated a record 580 new inventions last year and launched 25 startup companies ranging in scope from innovative therapies for the treatment of fibrosis to technologies that aid in substance abuse monitoring.